These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 28222434

  • 21. DDP-resistant ovarian cancer cells-derived exosomal microRNA-30a-5p reduces the resistance of ovarian cancer cells to DDP.
    Liu R, Zhang Y, Sun P, Wang C.
    Open Biol; 2020 Apr; 10(4):190173. PubMed ID: 32343928
    [Abstract] [Full Text] [Related]

  • 22. Effects of microRNA-1271 on ovarian cancer via inhibition of epithelial-mesenchymal transition and cisplatin resistance.
    Chen Y, Wang L, Zhou J.
    J Obstet Gynaecol Res; 2019 Nov; 45(11):2243-2254. PubMed ID: 31411791
    [Abstract] [Full Text] [Related]

  • 23. Exosomal lncRNA HEIH promotes cisplatin resistance in tongue squamous cell carcinoma via targeting miR-3619-5p/HDGF axis.
    Wang X, Yu H, Yu Z, Wang D.
    Acta Histochem; 2020 Dec; 122(8):151647. PubMed ID: 33130420
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Forkhead Box Protein C2 Promotes Epithelial-Mesenchymal Transition, Migration and Invasion in Cisplatin-Resistant Human Ovarian Cancer Cell Line (SKOV3/CDDP).
    Li C, Ding H, Tian J, Wu L, Wang Y, Xing Y, Chen M.
    Cell Physiol Biochem; 2016 Dec; 39(3):1098-110. PubMed ID: 27562816
    [Abstract] [Full Text] [Related]

  • 26. MiR-30 suppresses lung cancer cell 95D epithelial mesenchymal transition and invasion through targeted regulating Snail.
    Fan MJ, Zhong YH, Shen W, Yuan KF, Zhao GH, Zhang Y, Wang SK.
    Eur Rev Med Pharmacol Sci; 2017 Jun; 21(11):2642-2649. PubMed ID: 28678320
    [Abstract] [Full Text] [Related]

  • 27. miR-194-5p inhibits SLC40A1 expression to induce cisplatin resistance in ovarian cancer.
    Wu J, Zhang L, Wu S, Yi X, Liu Z.
    Pathol Res Pract; 2020 Jul; 216(7):152979. PubMed ID: 32534701
    [Abstract] [Full Text] [Related]

  • 28. MicroRNA-30a increases tight junction protein expression to suppress the epithelial-mesenchymal transition and metastasis by targeting Slug in breast cancer.
    Chang CW, Yu JC, Hsieh YH, Yao CC, Chao JI, Chen PM, Hsieh HY, Hsiung CN, Chu HW, Shen CY, Cheng CW.
    Oncotarget; 2016 Mar 29; 7(13):16462-78. PubMed ID: 26918943
    [Abstract] [Full Text] [Related]

  • 29. MiR-211 is epigenetically regulated by DNMT1 mediated methylation and inhibits EMT of melanoma cells by targeting RAB22A.
    Yu H, Yang W.
    Biochem Biophys Res Commun; 2016 Aug 05; 476(4):400-405. PubMed ID: 27237979
    [Abstract] [Full Text] [Related]

  • 30. MiR-30a-5p confers cisplatin resistance by regulating IGF1R expression in melanoma cells.
    Li Y, Zhang J, Liu Y, Zhang B, Zhong F, Wang S, Fang Z.
    BMC Cancer; 2018 Apr 11; 18(1):404. PubMed ID: 29642855
    [Abstract] [Full Text] [Related]

  • 31. Triptolide antagonized the cisplatin resistance in human ovarian cancer cell line A2780/CP70 via hsa-mir-6751.
    Wang R, Ma X, Su S, Liu Y.
    Future Med Chem; 2018 Aug 01; 10(16):1947-1955. PubMed ID: 29966441
    [Abstract] [Full Text] [Related]

  • 32. MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine.
    Xiang Y, Ma N, Wang D, Zhang Y, Zhou J, Wu G, Zhao R, Huang H, Wang X, Qiao Y, Li F, Han D, Wang L, Zhang G, Gao X.
    Oncogene; 2014 Jan 16; 33(3):378-86. PubMed ID: 23318422
    [Abstract] [Full Text] [Related]

  • 33. Decreased miR-30b-5p expression by DNMT1 methylation regulation involved in gastric cancer metastasis.
    Qiao F, Zhang K, Gong P, Wang L, Hu J, Lu S, Fan H.
    Mol Biol Rep; 2014 Sep 16; 41(9):5693-700. PubMed ID: 24913034
    [Abstract] [Full Text] [Related]

  • 34. Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway.
    Li WF, Dai H, Ou Q, Zuo GQ, Liu CA.
    Tumour Biol; 2016 May 16; 37(5):5885-95. PubMed ID: 26589417
    [Abstract] [Full Text] [Related]

  • 35. miR-148a-3p represses proliferation and EMT by establishing regulatory circuits between ERBB3/AKT2/c-myc and DNMT1 in bladder cancer.
    Wang X, Liang Z, Xu X, Li J, Zhu Y, Meng S, Li S, Wang S, Xie B, Ji A, Liu B, Zheng X, Xie L.
    Cell Death Dis; 2016 Dec 01; 7(12):e2503. PubMed ID: 27906180
    [Abstract] [Full Text] [Related]

  • 36. miR-142-5p enhances cisplatin-induced apoptosis in ovarian cancer cells by targeting multiple anti-apoptotic genes.
    Li X, Chen W, Jin Y, Xue R, Su J, Mu Z, Li J, Jiang S.
    Biochem Pharmacol; 2019 Mar 01; 161():98-112. PubMed ID: 30639456
    [Abstract] [Full Text] [Related]

  • 37. miR-206 regulates cisplatin resistance and EMT in human lung adenocarcinoma cells partly by targeting MET.
    Chen QY, Jiao DM, Wang J, Hu H, Tang X, Chen J, Mou H, Lu W.
    Oncotarget; 2016 Apr 26; 7(17):24510-26. PubMed ID: 27014910
    [Abstract] [Full Text] [Related]

  • 38. MicroRNA-106a-5p alleviated the resistance of cisplatin in lung cancer cells by targeting Jumonji domain containing 6.
    Ge X, Jiang Y, Hu X, Yu X.
    Transpl Immunol; 2021 Dec 26; 69():101478. PubMed ID: 34607003
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.